Delivery Order SPE2DB20D3103-SPE2DB24FQ1E7

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,448.90 firm fixed-price delivery order is for the supply of 2 mg Remifentanil vials, a specialty medication used for pain management. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,667.20 firm fixed-price delivery order is for the supply of 1 mg vials of the medication Remifentanil. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This contract award is a delivery order worth $5,696.14 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Remifentanil 1 mg vials, a specialty medication used for pain management. The contract has an ultimate completion date of November 28, 2023 and is a firm fixed price arrangement. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,632.60 firm fixed price contract is for the delivery of 4,568,194,784 units of Remifentanil 2MG, a medication used for pain management. The award has an ultimate completion date of May 12, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,637.53 firm fixed-price contract is for the delivery of remifentanil 2 mg vials, a specialty medication used for pain management. The delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,239.30 Firm Fixed Price Delivery Order covers the supply of 1 mg vials of the medication Remifentanil. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of REMIFENTANIL 1 MG VIALS. The delivery order contract, valued at $5,149.43, has a firm fixed price and is set to expire on October 22, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,539.29 firm fixed-price contract is for the provision of Remifentanil 2 mg vials, a medication used for pain management. The contract has an ultimate completion date of January 30, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $3,897.31 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Remifentanil 2 mg vials, a medication used for pain management. The contract has an ultimate completion date of July 11, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of REMIFENTANIL 1 MG VIALS. The $2,686.05 firm-fixed-price delivery order has a completion date of December 6, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FQ1E7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,206.08 firm fixed-price delivery order is for the supply of Remifentanil 1 mg vials, a specialty medication used for pain management. The contract has an ultimate completion date of September 4, 2024.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that larger IDC agreement. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:08 PM